Your browser doesn't support javascript.
loading
Oral transforming growth factor-beta receptor 1 inhibitor vactosertib promotes osteosarcoma regression by targeting tumor proliferation and enhancing anti-tumor immunity.
Choi, Sung Hee; Myers, Jay Thomas; Tomchuck, Suzanne Louise; Bonner, Melissa; Eid, Saada; Kingsley, Daniel Tyler; VanHeyst, Kristen Ashley; Kim, Seong-Jin; Kim, Byung-Gyu; Huang, Alex Yee-Chen.
Afiliación
  • Choi SH; Department of Pediatrics, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
  • Myers JT; Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
  • Tomchuck SL; Department of Pediatrics, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
  • Bonner M; Department of Pediatrics, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
  • Eid S; Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
  • Kingsley DT; Department of Pediatrics, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
  • VanHeyst KA; Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
  • Kim SJ; Department of Pediatrics, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
  • Kim BG; Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
  • Huang AY; MedPacto Inc., Seoul, Republic of Korea.
Cancer Commun (Lond) ; 2024 Jul 06.
Article en En | MEDLINE | ID: mdl-38970391
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Cancer Commun (Lond) Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Cancer Commun (Lond) Año: 2024 Tipo del documento: Article